179 related articles for article (PubMed ID: 23638194)
1. Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
Molina-Berríos A; Campos-Estrada C; Henriquez N; Faúndez M; Torres G; Castillo C; Escanilla S; Kemmerling U; Morello A; López-Muñoz RA; Maya JD
PLoS Negl Trop Dis; 2013; 7(4):e2173. PubMed ID: 23638194
[TBL] [Abstract][Full Text] [Related]
2. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
González-Herrera F; Cramer A; Pimentel P; Castillo C; Liempi A; Kemmerling U; Machado FS; Maya JD
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993857
[TBL] [Abstract][Full Text] [Related]
4. Aspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.
Malvezi AD; da Silva RV; Panis C; Yamauchi LM; Lovo-Martins MI; Zanluqui NG; Tatakihara VL; Rizzo LV; Verri WA; Martins-Pinge MC; Yamada-Ogatta SF; Pinge-Filho P
Mediators Inflamm; 2014; 2014():580919. PubMed ID: 25045211
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.
Silvero-Isidre A; Morínigo-Guayuán S; Meza-Ojeda A; Mongelós-Cardozo M; Centurión-Wenninger C; Figueredo-Thiel S; Sanchez DF; Acosta N
Parasitol Res; 2018 Jan; 117(1):189-200. PubMed ID: 29196837
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Campos-Estrada C; Liempi A; González-Herrera F; Lapier M; Kemmerling U; Pesce B; Ferreira J; López-Muñoz R; Maya JD
PLoS Negl Trop Dis; 2015 May; 9(5):e0003770. PubMed ID: 25978361
[TBL] [Abstract][Full Text] [Related]
7. Myenteric neuroprotective role of aspirin in acute and chronic experimental infections with Trypanosoma cruzi.
Oda JY; Belém MO; Carlos TM; Gouveia R; Luchetti BFC; Moreira NM; Massocatto CL; Araújo SM; Sant Ana DMG; Buttow NC; Pinge-Filho P; Araújo EJA
Neurogastroenterol Motil; 2017 Oct; 29(10):1-13. PubMed ID: 28524628
[TBL] [Abstract][Full Text] [Related]
8. Bioactive lipids in Trypanosoma cruzi infection.
Machado FS; Mukherjee S; Weiss LM; Tanowitz HB; Ashton AW
Adv Parasitol; 2011; 76():1-31. PubMed ID: 21884885
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites.
Basselin M; Ramadan E; Chen M; Rapoport SI
Neurochem Res; 2011 Jan; 36(1):139-45. PubMed ID: 20981485
[TBL] [Abstract][Full Text] [Related]
11. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin Improves Cardiac Function through Notch 1 Activation in BALB/c Mice with Chronic Chagas Cardiomyopathy.
Guzmán-Rivera D; Liempi A; González-Herrera F; Fuentes-Retamal S; Carrillo I; Abarca P; Castillo C; Kemmerling U; Pesce B; Maya JD
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393497
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.
Goh J; Baird AW; O'Keane C; Watson RW; Cottell D; Bernasconi G; Petasis NA; Godson C; Brady HR; MacMathuna P
J Immunol; 2001 Sep; 167(5):2772-80. PubMed ID: 11509622
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
15. 3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.
Knubel CP; Martínez FF; Acosta Rodríguez EV; Altamirano A; Rivarola HW; Diaz Luján C; Fretes RE; Cervi L; Motrán CC
PLoS One; 2011; 6(10):e26550. PubMed ID: 22028903
[TBL] [Abstract][Full Text] [Related]
16. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.
Esper L; Roman-Campos D; Lara A; Brant F; Castro LL; Barroso A; Araujo RR; Vieira LQ; Mukherjee S; Gomes ER; Rocha NN; Ramos IP; Lisanti MP; Campos CF; Arantes RM; Guatimosim S; Weiss LM; Cruz JS; Tanowitz HB; Teixeira MM; Machado FS
Am J Pathol; 2012 Jul; 181(1):130-40. PubMed ID: 22658486
[TBL] [Abstract][Full Text] [Related]
17. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
18. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.
Paláu MT; Mejía AJ; Vergara U; Zúñiga CA
Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):543-8. PubMed ID: 12937771
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
20. Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection.
Rodrigues CM; Valadares HM; Francisco AF; Arantes JM; Campos CF; Teixeira-Carvalho A; Martins-Filho OA; Araujo MS; Arantes RM; Chiari E; Franco GR; Machado CR; Pena SD; Faria AM; Macedo AM
PLoS Negl Trop Dis; 2010 Oct; 4(10):e846. PubMed ID: 20967289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
